Indian firms linked to cough syrup deaths had received warnings

FILE PHOTO-People stand outside the Maiden Pharmaceuticals plant that was sealed by the Indian government officials in 2022, in Sonipat in the northern state of Haryana, India, February 2, 2023. REUTERS/Adnan Abidi/File Photo

NEW DELHI (Reuters) - The deaths of 12 children in northern India between December 2019 and January 2020, police allege, were caused by adulterated cough syrup made by drugmaker Digital Vision. It was not the first time the company's medicines have come under scrutiny.

Indian drugs regulators found quality shortfalls in drugs made by Digital and its unit Orison Pharmaceuticals at least 22 times between 2012 and July this year, according to a Reuters review of records from five states and India's federal drugs regulator CDSCO.